Ubs Oconnor LLC X4 Pharmaceuticals, Inc Transaction History
Ubs Oconnor LLC
- $1.59 Billion
- Q1 2024
A detailed history of Ubs Oconnor LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 1,335,521 shares of XFOR stock, worth $1.28 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,335,521Holding current value
$1.28 Million% of portfolio
0.12%Shares
4 transactions
Others Institutions Holding XFOR
# of Institutions
106Shares Held
103MCall Options Held
206KPut Options Held
291K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$16.2 Million3.55% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$14.4 Million1.46% of portfolio
-
Black Rock Inc. New York, NY8.74MShares$8.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.83MShares$7.51 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$6.85 Million0.22% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $65.9M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...